Paper36949200
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Jbara A and 19 others. Nature, 2023. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Papers, record 36949200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Repressor Proteins | |
| RNA Splicing Factors | |
| Animals | |
| Neoplasm Metastasis | |
| Focal Adhesions | |
| Adaptor Proteins, Signal Transducing |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA013106 | NCI NIH HHS | United States | P01CA013106 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 37709754 | RBFOX2: a key factor in suppressing PDAC metastasis through regulation of alternative splicing events. | https://conductscience.org/library/papers/37709754 |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30686769 | Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30686769 | PubMed |
| 2 | 20981102 | Distant metastasis occurs late during the genetic evolution of pancreatic cancer. | Nature | 2010 | https://conductscience.org/library/papers/20981102 | PubMed |
| 3 | 28092682 | Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. | Nat Genet | 2017 | https://conductscience.org/library/papers/28092682 | PubMed |
| 4 | 18772397 | Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. | Science | 2008 | https://conductscience.org/library/papers/18772397 | PubMed |
| 5 | 25207767 | Pancreatic adenocarcinoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25207767 | PubMed |
| 6 | 26343385 | Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. | Nat Genet | 2015 | https://conductscience.org/library/papers/26343385 | PubMed |
| 7 | 21460848 | Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. | Nat Med | 2011 | https://conductscience.org/library/papers/21460848 | PubMed |
| 8 | 26909576 | Genomic analyses identify molecular subtypes of pancreatic cancer. | Nature | 2016 | https://conductscience.org/library/papers/26909576 | PubMed |
| 9 | 33477288 | The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33477288 | PubMed |
| 10 | 21178653 | Characterization of alternative spliceoforms and the RNA splicing machinery in pancreatic cancer. | Pancreas | 2011 | https://conductscience.org/library/papers/21178653 | PubMed |
| 11 | 28592875 | Splice variants as novel targets in pancreatic ductal adenocarcinoma. | Sci Rep | 2017 | https://conductscience.org/library/papers/28592875 | PubMed |
| 12 | 29288237 | Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29288237 | PubMed |
| 13 | 27768182 | Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/27768182 | PubMed |
| 14 | 31932696 | Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. | Nat Genet | 2020 | https://conductscience.org/library/papers/31932696 | PubMed |
| 15 | 31135034 | PSI-Sigma: a comprehensive splicing-detection method for short-read and long-read RNA-seq analysis. | Bioinformatics | 2019 | https://conductscience.org/library/papers/31135034 | PubMed |
| 16 | 14697350 | Cell migration: Rho GTPases lead the way. | Dev Biol | 2004 | https://conductscience.org/library/papers/14697350 | PubMed |
| 17 | 27104978 | Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR. | Cell | 2016 | https://conductscience.org/library/papers/27104978 | PubMed |
| 18 | 32807990 | Concentration-dependent splicing is enabled by Rbfox motifs of intermediate affinity. | Nat Struct Mol Biol | 2020 | https://conductscience.org/library/papers/32807990 | PubMed |
| 19 | 34244793 | RBFOX2 alters splicing outcome in distinct binding modes with multiple protein partners. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34244793 | PubMed |
| 20 | 28489577 | Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. | Oncotarget | 2017 | https://conductscience.org/library/papers/28489577 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926692 | A unified framework for quantitative splicing and transcript prediction. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926692 | PubMed |
| 42897138 | FAM50A promotes esophageal squamous cell carcinoma progression via splicing-dependent oncogenic circSDK1- and DUSP22-mediated MAPK/FAK activation. | Cell Discov | 2026 | https://conductscience.org/library/papers/42897138 | PubMed |
| 42870295 | U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoint integrity. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42870295 | PubMed |
| 42864337 | RAISE quantifies RNA binding protein activity via transcriptomic profiling. | Nat Commun | 2026 | https://conductscience.org/library/papers/42864337 | PubMed |
| 42686855 | Triglyceride enhancs NSCLC metastasis via lipid β-oxidation by RhoA-driven cytoskeletal remodeling in ECM-constrained microenvironments. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42686855 | PubMed |
| 42477458 | Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42477458 | PubMed |
| 42260649 | Nonsense-mediated mRNA decay: friend or foe in cancer biology? | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42260649 | PubMed |
| 42223720 | The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42223720 | PubMed |
| 41998316 | Tools and tactics for studying alternative splicing. | Nat Rev Genet | 2026 | https://conductscience.org/library/papers/41998316 | PubMed |
| 41675711 | Mycobacterial PstP impairs host RNA alternative splicing by dephosphorylation of spliceosome RBMX at S189. | IMetaOmics | 2025 | https://conductscience.org/library/papers/41675711 | PubMed |
| 41668133 | CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41668133 | PubMed |
| 41584352 | Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584352 | PubMed |
| 41491254 | Mapping isoforms and regulatory mechanisms from spatial transcriptomics data with SPLISOSM. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/41491254 | PubMed |
| 41477346 | m6A readers: Promising therapeutic targets in cancer treatment. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41477346 | PubMed |
| 41462255 | LAPTM5 drives omental metastasis in high-grade serous ovarian cancer via TGF-β/Smad-mediated epithelial plasticity. | J Transl Med | 2025 | https://conductscience.org/library/papers/41462255 | PubMed |
| 41418788 | RBFOX2-dependent alternative splicing of Numb regulates Notch signaling during muscle stem cell activation. | Stem Cell Reports | 2026 | https://conductscience.org/library/papers/41418788 | PubMed |
| 41337583 | Rbfox2 selectively governs hematopoietic stem cell self-renewal by regulating proteostasis. | Sci Adv | 2025 | https://conductscience.org/library/papers/41337583 | PubMed |
| 41256595 | SpliceDecoder: A High-Throughput Tool for Guiding the Functional Interpretation of Differential Splicing Events. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256595 | PubMed |
| 41188645 | KATMAP infers splicing factor activity and regulatory targets from knockdown data. | Nat Biotechnol | 2025 | https://conductscience.org/library/papers/41188645 | PubMed |
| 40990037 | AEnet: a practical tool to construct the splicing-associated phenotype atlas at a single cell level. | Gigascience | 2025 | https://conductscience.org/library/papers/40990037 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949200
GET https://conductscience.org/api/papers/v1/36949200/references?page=2